Latest filing published 04 Sept 2018 for Reviva Pharmaceuticals Holdings, INC., €283k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rahul Nayar: trading record in brief
Rahul Nayar is a declared insider of Reviva Pharmaceuticals Holdings, Inc., with filings sourced from SEC (Form 4). We count 2 filings; the first trade dates from 23 August 2018 and the latest from 30 August 2018.
On the market, this insider has only ever bought: 2 purchases, €3.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 4 September 2018 came the latest disclosure, an open-market purchase for €283k in Reviva Pharmaceuticals Holdings, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rahul Nayar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,000 shares@ US$10.00Ordinary SharesSEC:0001144204-18-047844:0Canonical exit: 28 Nov 2018 (T+90)
- 310,000 shares@ US$10.00Ordinary SharesSEC:0001144204-18-046300:0Canonical exit: 21 Nov 2018 (T+90)
2 of 2 declarations